Historical Valuation
Compugen Ltd (CGEN) is now in the Overvalued zone, suggesting that its current forward PS ratio of 28.39 is considered Overvalued compared with the five-year average of -27.63. The fair price of Compugen Ltd (CGEN) is between 0.69 to 1.76 according to relative valuation methord. Compared to the current price of 1.83 USD , Compugen Ltd is Overvalued By 4.06%.
Relative Value
Fair Zone
0.69-1.76
Current Price：1.83
4.06%
Overvalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
Compugen Ltd (CGEN) has a current Price-to-Book (P/B) ratio of 3.31. Compared to its 3-year average P/B ratio of 2.29 , the current P/B ratio is approximately 44.23% higher. Relative to its 5-year average P/B ratio of 2.89, the current P/B ratio is about 14.42% higher. Compugen Ltd (CGEN) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of -5.15%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of -5.47% , the current FCF yield is about -100.00% lower.
P/B
Median3y
2.29
Median5y
2.89
FCF Yield
Median3y
-5.15
Median5y
-5.47
Competitors Valuation Multiple
AI Analysis for CGEN
The average P/S ratio for CGEN competitors is 20.52, providing a benchmark for relative valuation. Compugen Ltd Corp (CGEN.O) exhibits a P/S ratio of 28.39, which is 38.37% above the industry average. Given its robust revenue growth of -88.96%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for CGEN
1Y
3Y
5Y
Market capitalization of CGEN increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of CGEN in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is CGEN currently overvalued or undervalued?
Compugen Ltd (CGEN) is now in the Overvalued zone, suggesting that its current forward PS ratio of 28.39 is considered Overvalued compared with the five-year average of -27.63. The fair price of Compugen Ltd (CGEN) is between 0.69 to 1.76 according to relative valuation methord. Compared to the current price of 1.83 USD , Compugen Ltd is Overvalued By 4.06% .
What is Compugen Ltd (CGEN) fair value?
CGEN's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Compugen Ltd (CGEN) is between 0.69 to 1.76 according to relative valuation methord.
How does CGEN's valuation metrics compare to the industry average?
The average P/S ratio for CGEN's competitors is 20.52, providing a benchmark for relative valuation. Compugen Ltd Corp (CGEN) exhibits a P/S ratio of 28.39, which is 38.37% above the industry average. Given its robust revenue growth of -88.96%, this premium appears unsustainable.
What is the current P/B ratio for Compugen Ltd (CGEN) as of Jan 09 2026?
As of Jan 09 2026, Compugen Ltd (CGEN) has a P/B ratio of 3.31. This indicates that the market values CGEN at 3.31 times its book value.
What is the current FCF Yield for Compugen Ltd (CGEN) as of Jan 09 2026?
As of Jan 09 2026, Compugen Ltd (CGEN) has a FCF Yield of 0.00%. This means that for every dollar of Compugen Ltd’s market capitalization, the company generates 0.00 cents in free cash flow.
What is the current Forward P/E ratio for Compugen Ltd (CGEN) as of Jan 09 2026?
As of Jan 09 2026, Compugen Ltd (CGEN) has a Forward P/E ratio of -5.04. This means the market is willing to pay $-5.04 for every dollar of Compugen Ltd’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Compugen Ltd (CGEN) as of Jan 09 2026?
As of Jan 09 2026, Compugen Ltd (CGEN) has a Forward P/S ratio of 28.39. This means the market is valuing CGEN at $28.39 for every dollar of expected revenue over the next 12 months.